
Tambua Health uses lung sound analysis to transform the diagnosis and treatment of respiratory diseases. The company offers precise, non-invasive, and radiation-free lung imaging and lung function testing using acoustic technology. The company was founded in 2018 by Daniel Gathigai and Lewis Wanjohi.

Tambua Health uses lung sound analysis to transform the diagnosis and treatment of respiratory diseases. The company offers precise, non-invasive, and radiation-free lung imaging and lung function testing using acoustic technology. The company was founded in 2018 by Daniel Gathigai and Lewis Wanjohi.
Focus: Acoustic lung and cardiopulmonary sound analysis for non‑invasive diagnosis and monitoring
Founded: 2018
Headquarters: San Francisco Bay Area
Funding: Seed (Apr 17, 2020); total disclosed funding USD 250,000
Notable investors: Y Combinator; Ventures Platform
Team size (approx.): 6 employees
Respiratory and cardiopulmonary disease diagnosis and treatment
2018
Medical technology
“Investors include Y Combinator and Ventures Platform; other listed backers include Backstage Capital, Asymmetry Ventures, Silverbacks Holdings, and Wuri Ventures. Ventures Platform led the Apr 17, 2020 Seed round.”